相关实验视频
Updated: Jan 15, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.1K
二型艾伯内斯形呈现心力衰竭:一个病例报告
Yanan Gu1, Jianjun Luo1, Yi Chen1
1Department of Interventional Radiology, Zhongshan Hospital and Shanghai Institute of Medical Imaging, Fudan University, Shanghai, 200032, China.
Radiology case reports
|October 6, 2025
概括
kongenital extrahepatic portosystemic shunt (CEPS) 是一种罕见的血管异常. 血管内栓塞成功地治疗了患有Abernethy形的患者的心力衰竭症状,而没有增加门口压力.
科学领域:
- 血管外科 血管外科
- 干预性放射学 干预性放射学
- 心脏病学 心脏病学
背景情况:
- kongenital extrahepatic portosystemic shunt (CEPS) 或Abernethy形是一种罕见的血管异常.
- 它涉及门静脉 (PV) 和下腔静脉 (IVC) 之间的异常连接.
- CEPS可能会出现各种症状,包括心脏并发症.
研究的目的:
- 报告一个Abernethy形病例与心力衰竭.
- 描述CEPS的诊断和内血管治疗方法.
- 突出在精选患者中单次栓塞的可行性.
主要方法:
- 诊断成像 (例如,CT血管造影) 以确定突变解剖.
- 血管内线圈栓塞以封闭异常血管.
- 术前和术后对心脏功能和症状的评估.
主要成果:
- 一名患有CEPS的51岁男子出现了显著的心力衰竭症状.
- 顺利地进行了一次性静脉内线圈栓塞的分流.
- 患者在手术后的心力衰竭症状显著改善.
- 没有发现 portal 压力升高,支持治疗可行性.
结论:
- 艾伯内蒂形可以表现为心力衰竭,模仿原发性心脏病.
- 血管内栓塞是一种安全有效的CEPS治疗方法.
- 在没有 portal 压力升高的患者中,单次静脉栓塞是可行的,导致症状消失.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
401
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
401
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468
Mitral Regurgitation I: Introduction
415
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
415
Heart Failure I: Introduction
693
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
693
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Heart Failure IV: Classification and Diagnostic Evaluation
319
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
319

